In general, the value of CCL18 for predicting acute exacerbation of IPF (AE-IPF), a process of rapid deterioration and a major cause of morbidity and mortality in IPF, remains controversial, and correlative research is limited [88,89]; this topic warrants further investigation. Here, CCL18 is linked to idiopathic pulmonary fibrosis.